(BOSTON, MA) August 29, 2019 – Invicro LLC, a Konica Minolta company and a leading provider of imaging biomarkers, core lab services and software for research and drug development, today announced the appointment of Mr. Hidenori Seshimo, M. Eng. as Vice President of Biomarker Services, Japan.
Invicro and iThera Medical Announce a Strategic Partnership to Enhance in vivo Imaging Capabilities with the MSOT inVision Optoacoustic Imaging Platform
(Boston, MA and Munich, Germany) April 30, 2019 – Invicro LLC, a Konica Minolta company and iTheraMedical GmbH announced a unique partnership with the placement of the MSOT inVision platform in Invicro’s in vivo laboratory out of its Boston headquarters. Both companies will come together to uniquely offer Pharmaceutical, Biotech and Academia sponsors services from the optoacoustic platform that will identify and quantify disease-related biomarkers at both a molecular and anatomical level through pre-clinical full body tomographic scans.
Invicro and icometrix Announce a Unique Partnership to Provide an Automated Workflow for Imaging Core Lab Services and Advanced Informatics to Pharmaceutical and Biotechnology Sponsors Worldwide
(Boston, MA and Leuven, Belgium) February 25, 2019 – Invicro LLC, a Konica Minolta company and icometrix jointly announced a partnership that will seamlessly offer the world’s most comprehensive breadth of imaging core lab services combined with the most robust FDA-cleared MRI informatics capabilities through automated workflows. Pharmaceutical sponsors will experience one point of contact for study site set-up and training which will harmonize with a single platform for data management, sharing and analytics.
Invicro Appoints Dr. Joseph Krueger as Vice President, Research and Applications for Advanced Pathology Services
BOSTON, MA, February 14, 2019 – Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the hiring of Dr. Joseph Krueger as Vice President, Research and Applications for Advanced Pathology Services.
Konica Minolta Launches Dedicated Precision Medicine Business in Japan
Tokyo, Japan (September 26, 2018 – article source from Business Wire): Konica Minolta, Inc. (“Konica Minolta”) (TOKYO: 4902) (ISIN: JP3300600008) today announced the launch of Konica Minolta Precision Medicine Japan, Inc. (“KMPMJ”) which will start operations on October 1, 2018. KMPMJ is a 100%-owned subsidiary of Konica Minolta with responsibility for marketing high-end precision medicine tools and diagnostic services in Japan. Precision medicine is medical care that uses genetic and molecular profiling to optimize treatment for specific groups of patients.
Invicro and Enigma Biomedical Group Sign a Collaboration Agreement
Toronto, Canada (August 20, 2018): Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug development, to work together on multiple projects, initially focusing on the enhancement of Invicro’s AmyloidIQ and TauIQ platforms. EBG will be responsible for providing data from their affiliate companies; Cerveau Technologies, Inc. and Meilleur Technologies, Inc.; novel Tau tracer (MK-6240) and Amyloid tracer (NAV-4694); respectively.
Dr. John E. Niederhuber Appointed Chairman of Konica Minolta’s Scientific Advisory Board
Aliso Viejo, CA (July 10, 2018): Konica Minolta Precision Medicine Inc., a newly formed division of Konica Minolta focused on revolutionizing personalized patient care, announced today the appointment of Dr. John E. Niederhuber as the Chairman of their Scientific Advisory Board.
Invicro Names Dr. Brian Avants as Senior Director of Machine Learning
BOSTON, MA, August 2, 2018 – Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the appointment of Brian Avants, Ph.D. as Senior Director of Machine Learning.
Invicro Scientists Awarded Alavi-Mandell Publication Award and Named Finalist for the Ziskind-Somerfeld Research Award
BOSTON, MA, July 19, 2018 – Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, announces that a study conducted at Invicro London (formerly Imanova) has been awarded the Alavi-Mandell Publication Award by the Journal of Nuclear Medicine (JNM) for the publication entitled, “11C-PBR28 or 18F-PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis”. Dr Gourab Datta, of Imperial College, London is lead author and award recipient. Invicro’s Dr. Eugenii (Ilan) Rabiner, EVP Head of Translational Imaging and Dr. Roger Gunn, EVP of Quantitative Data Sciences are named co-authors.
Invicro Hires Peter Genakos as New Haven’s General Manager
BOSTON, MA, April 20, 2018 – Invicro, LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the appointment of Mr. Peter Genakos, J.D. as General Manager of the New Haven, CT office.